Safety and Efficacy Study of A Viscoelastic-free Method for Implantable Collamer Lens (ICL) Implantation
Key facts
- Who runs it
- Wenzhou Medical University
- Where
- China5 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 60 people, planned
- Started
- 16 Nov 2018
- Expected to end
- 22 Jun 2028
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- viscoelastic-free implantation system
- standard viscoelastic-assisted Implantation system
- Record updated
- 18 August 2026
Who can take part
- Age
- 18 years to 45 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Documented stable refraction for at least 1 year(within 0.5D)
- Best spectacle-corrected visual acuity (BCVA) of 20/40 or better
- Clear central cornea
- -0.5D to -18.0D of myopic refractive error
- Normal anterior chamber depth at least 2.8 mm to endothelium
- Endothelial cell density (ECD) more than 2000 cell/mm2
- Pupil diameter smaller than 7.0 mm under mesopic condition
- Discontinued 3 weeks for hard contact lens and 1 week for soft contact lens wear
Who cannot take part
- Preexisting ocular diseases or conditions other than myopia, evidence of progressive or acute ocular disease
- Evidence of connective tissue disease or other systemic diseases that may confound the results of the study
- Narrow angle of anterior chamber
- Pregnant, lactating, or planning to become pregnant during the course of the trial
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 45 years old?
This trial is currently available in China.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study evaluates the safety and efficacy of a viscoelastic-free method for Implantable Collamer Lens(ICL) implantation to treat high myopia. The subjects undergo randomization of ICL implantation using the viscoelastic-free method on one eye and undergoing standard method on the other one. The post-operative data are collected for analysis.
The 2 groups in the trial
- viscoelastic-free systemTreatment being tested
Eyes in this group will use viscoelastic-free implantation system during the surgery
Treatment: viscoelastic-free implantation system
- viscoelastic-assisted systemExisting treatment, for comparison
Eyes in this group will utilize the standard viscoelastic-assisted Implantation system during the surgery
Treatment: standard viscoelastic-assisted Implantation system
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Prospective, Multicenter,Randomized Clinical Investigation of A Viscoelastic-free Method for Implantable Collamer Lens (ICL) Implantation to Treat High Myopia: A Pilot Study
- Criteria questions
- Built from NCT03059043, who can take part
- Record updated
- 18 August 2026